Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donald J. Krogstad is active.

Publication


Featured researches published by Donald J. Krogstad.


The EMBO Journal | 2005

A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance

Viswanathan Lakshmanan; Patrick G. Bray; Dominik Verdier-Pinard; David J. Johnson; Paul Horrocks; Rebecca A. Muhle; George E Alakpa; Ruth H. Hughes; Steve A. Ward; Donald J. Krogstad; Amar Bir Singh Sidhu; David A. Fidock

Chloroquine resistance (CQR) in Plasmodium falciparum is associated with mutations in the digestive vacuole transmembrane protein PfCRT. However, the contribution of individual pfcrt mutations has not been clarified and other genes have been postulated to play a substantial role. Using allelic exchange, we show that removal of the single PfCRT amino‐acid change K76T from resistant strains leads to wild‐type levels of CQ susceptibility, increased binding of CQ to its target ferriprotoporphyrin IX in the digestive vacuole and loss of verapamil reversibility of CQ and quinine resistance. Our data also indicate that PfCRT mutations preceding residue 76 modulate the degree of verapamil reversibility in CQ‐resistant lines. The K76T mutation accounts for earlier observations that CQR can be overcome by subtly altering the CQ side‐chain length. Together, these findings establish PfCRT K76T as a critical component of CQR and suggest that CQ access to ferriprotoporphyrin IX is determined by drug–protein interactions involving this mutant residue.


Emerging Infectious Diseases | 2007

Prevalence of Plasmodium falciparum Infection in Rainy Season, Artibonite Valley, Haiti, 2006

Thomas P. Eisele; Joseph Keating; Adam Bennett; Berlin Londono; Dawn Johnson; Christina Lafontant; Donald J. Krogstad

We conducted a population-based survey to estimate the prevalence of Plasmodium falciparum infection among persons older than 1 month in the Artibonite Valley of Haiti during the high malaria transmission season in 2006. Results from PCR for 714 persons showed a prevalence of 3.1% for P. falciparum infection.


Emerging Infectious Diseases | 2009

Chloroquine-Resistant Haplotype Plasmodium falciparum Parasites, Haiti

Berlin Londono; Thomas P. Eisele; Joseph Keating; Adam Bennett; Chandon Chattopadhyay; Gaetan Heyliger; Brian Mack; Ian Rawson; Jean-Francois Vely; Olbeg Désinor; Donald J. Krogstad

Chloroquine resistance is now present in this country.


The Journal of Infectious Diseases | 2010

INCREASED PULMONARY PRESSURES AND MYOCARDIAL WALL STRESS IN CHILDREN WITH SEVERE MALARIA

Jacqueline Janka; Ousmane Koita; Broulaye Traoré; Josépha M. Traoré; Fawaz Mzayek; Vandana Sachdev; Xunde Wang; Kassoum Sanogo; Lansana Sangaré; Laurel Mendelsohn; Henry Masur; Gregory J. Kato; Mark T. Gladwin; Donald J. Krogstad

BACKGROUND Chronic intravascular hemolysis leads to nitric oxide (NO) depletion and pulmonary hypertension in sickle cell disease. To test whether this pathophysiology occurs in malaria, we examined in Mali 53 children who were admitted to the hospital with severe malaria (excluding cerebral malaria) and 31 age-matched controls. METHODS Severity of hemolysis was assessed from plasma levels of free hemoglobin and arginase-1. NO metabolism was assessed by whole-blood nitrite levels and plasma NO consumption. Effects on the cardiovascular system and endothelial function were assessed by using echocardiography to measure peak tricuspid regurgitant jet velocity and by evaluating plasma levels of N-terminal prohormone brain natriuretic peptide (NT-proBNP) and soluble vascular cell adhesion molecule-1. RESULTS Children with severe malaria had higher plasma levels of hemoglobin and arginase-1, reduced whole-blood levels of nitrite, and increased NO consumption relative to controls. They also had increased pulmonary arterial pressures (P< .05) with elevated levels of NT-proBNP and soluble vascular cell adhesion molecule-1 (P< .001). CONCLUSION Children with severe malaria have increased pulmonary pressures and myocardial wall stress. These complications are consistent with NO depletion from intravascular hemolysis, and they indicate that the pathophysiologic cascade from intravascular hemolysis to NO depletion and its cardiopulmonary effects is activated in children with severe malaria.


Antimicrobial Agents and Chemotherapy | 2011

4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses.

Simon J. Hocart; Huayin Liu; Haiyan Deng; Dibyendu De; Frances M. Krogstad; Donald J. Krogstad

ABSTRACT Chloroquine (CQ) is a safe and economical 4-aminoquinoline (AQ) antimalarial. However, its value has been severely compromised by the increasing prevalence of CQ resistance. This study examined 108 AQs, including 68 newly synthesized compounds. Of these 108 AQs, 32 (30%) were active only against CQ-susceptible Plasmodium falciparum strains and 59 (55%) were active against both CQ-susceptible and CQ-resistant P. falciparum strains (50% inhibitory concentrations [IC50s], ≤25 nM). All AQs active against both CQ-susceptible and CQ-resistant P. falciparum strains shared four structural features: (i) an AQ ring without alkyl substitution, (ii) a halogen at position 7 (Cl, Br, or I but not F), (iii) a protonatable nitrogen at position 1, and (iv) a second protonatable nitrogen at the end of the side chain distal from the point of attachment to the AQ ring via the nitrogen at position 4. For activity against CQ-resistant parasites, side chain lengths of ≤3 or ≥10 carbons were necessary but not sufficient; they were identified as essential factors by visual comparison of 2-dimensional (2-D) structures in relation to the antiparasite activities of the AQs and were confirmed by computer-based 3-D comparisons and differential contour plots of activity against P. falciparum. The advantage of the method reported here (refinement of quantitative structure-activity relationship [QSAR] descriptors by random assignment of compounds to multiple training and test sets) is that it retains QSAR descriptors according to their abilities to predict the activities of unknown test compounds rather than according to how well they fit the activities of the compounds in the training sets.


Acta Tropica | 2012

Application of genomics to field investigations of malaria by the international centers of excellence for malaria research

Sarah K. Volkman; Daouda Ndiaye; Mahamadou Diakite; Ousmane Koita; Davis Nwakanma; Rachel Daniels; Daniel J. Park; Daniel E. Neafsey; Marc A. T. Muskavitch; Donald J. Krogstad; Pardis C. Sabeti; Daniel L. Hartl; Dyann F. Wirth

Success of the global research agenda toward eradication of malaria will depend on development of new tools, including drugs, vaccines, insecticides and diagnostics. Genomic information, now available for the malaria parasites, their mosquito vectors, and human host, can be leveraged to both develop these tools and monitor their effectiveness. Although knowledge of genomic sequences for the malaria parasites, Plasmodium falciparum and Plasmodium vivax, have helped advance our understanding of malaria biology, simply knowing this sequence information has not yielded a plethora of new interventions to reduce the burden of malaria. Here we review and provide specific examples of how genomic information has increased our knowledge of parasite biology, focusing on P. falciparum malaria. We then discuss how population genetics can be applied toward the epidemiological and transmission-related goals outlined by the International Centers of Excellence for Malaria Research groups recently established by the National Institutes of Health. Finally, we propose genomics is a research area that can promote coordination and collaboration between various ICEMR groups, and that working together as a community can significantly advance the value of this information toward reduction of the global malaria burden.


Malaria Journal | 2017

False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission

Christina T. Kozycki; Noella Umulisa; Stephen Rulisa; Emil I. Mwikarago; Jean Pierre Musabyimana; Jean Pierre Habimana; Corine Karema; Donald J. Krogstad

BackgroundRapid diagnostic tests (RDTs) for histidine rich protein 2 (HRP2) are often used to determine whether persons with fever should be treated with anti-malarials. However, Plasmodium falciparum parasites with a deletion of the hrp2 gene yield false-negative RDTs and there are concerns the sensitivity of HRP2-based RDTs may fall when the intensity of transmission decreases.MethodsThis observational study enrolled 9226 patients at three health centres in Rwanda from April 2014 to April 2015. It then compared the sensitivity of RDTs based on HRP2 and the Plasmodium lactate dehydrogenase (pLDH) to microscopy (thick smears) for the diagnosis of malaria. PCR was used to determine whether deletions of the histidine-rich central repeat region of the hrp2 gene (exon 2) were associated with false-negative HRP2-based RDTs.ResultsIn comparison to microscopy, the sensitivity and specificity of HRP2- and pLDH-based RDTs were 89.5 and 86.2% and 80.2 and 94.3%, respectively. When the results for both RDTs were combined, sensitivity rose to 91.8% and specificity was 85.7%. Additionally, when smear positivity fell from 46 to 3%, the sensitivity of the HRP2-based RDT fell from 88 to 67%. Of 370 samples with false-negative HRP2 RDT results for which PCR was performed, 140 (38%) were identified as P. falciparum by PCR. Of the isolates identified as P. falciparum by PCR, 32 (23%) were negative for the hrp2 gene based on PCR. Of the 32 P. falciparum isolates negative for hrp2 by PCR, 17 (53%) were positive based on the pLDH RDT.ConclusionThis prospective study of RDT performance coincided with a decline in the intensity of malaria transmission in Kibirizi (fall in slide positivity from 46 to 3%). This decline was associated with a decrease in HRP2 RDT sensitivity (from 88 to 67%). While P. falciparum isolates without the hrp2 gene were an important cause of false-negative HRP2-based RDTs, most were identified by the pLDH-based RDT. Although WHO does not recommend the use of combined HRP2/pLDH testing in sub-Saharan Africa, these results suggest that combination HRP2/pLDH-based RDTs could reduce the impact of false-negative HRP2-based RDTs for detection of symptomatic P. falciparum malaria.


American Journal of Tropical Medicine and Hygiene | 2015

Urban Malaria: Understanding its Epidemiology, Ecology, and Transmission across Seven Diverse ICEMR Network Sites

Mark L. Wilson; Donald J. Krogstad; Emmanuel Arinaitwe; Myriam Arevalo-Herrera; Laura Chery; Marcelo U. Ferreira; Daouda Ndiaye; Don P. Mathanga; Alex Eapen

A major public health question is whether urbanization will transform malaria from a rural to an urban disease. However, differences about definitions of urban settings, urban malaria, and whether malaria control should differ between rural and urban areas complicate both the analysis of available data and the development of intervention strategies. This report examines the approach of the International Centers of Excellence for Malaria Research (ICEMR) to urban malaria in Brazil, Colombia, India (Chennai and Goa), Malawi, Senegal, and Uganda. Its major theme is the need to determine whether cases diagnosed in urban areas were imported from surrounding rural areas or resulted from transmission within the urban area. If infections are being acquired within urban areas, malaria control measures must be targeted within those urban areas to be effective. Conversely, if malaria cases are being imported from rural areas, control measures must be directed at vectors, breeding sites, and infected humans in those rural areas. Similar interventions must be directed differently if infections were acquired within urban areas. The hypothesis underlying the ICEMR approach to urban malaria is that optimal control of urban malaria depends on accurate epidemiologic and entomologic information about transmission.


Acta Tropica | 2012

Sahel, Savana, Riverine and Urban Malaria in West Africa: Similar Control Policies with Different Outcomes

Serign J. Ceesay; Kalifa Bojang; Davis Nwakanma; David J. Conway; Ousmane Koita; Seydou Doumbia; Daouda Ndiaye; Tinzana F. Coulibaly; Mahamadou Diakite; Sekou F. Traore; Mamadou Coulibaly; Jean Louis Ndiaye; Ousmane Sarr; Oumar Gaye; Lassana Konate; Ngayo Sy; Babacar Faye; Ousmane Faye; Nafomon Sogoba; Musa Jawara; Adama Dao; Belco Poudiougou; Sory I. Diawara; Joseph Okebe; Lansana Sangaré; Ismaela Abubakar; Aliou Sissako; Ayouba Diarra; Moussa Keita; Balla Kandeh

The study sites for the West African ICEMR are in three countries (The Gambia, Senegal, Mali) and are located within 750 km of each other. In addition, the National Malaria Control Programmes of these countries have virtually identical policies: (1) Artemisinin Combination Therapies (ACTs) for the treatment of symptomatic Plasmodium falciparum infection, (2) Long-Lasting Insecticide-treated bed Nets (LLINs) to reduce the Entomololgic Inoculation Rate (EIR), and (3) sulfadoxine-pyrimethamine for the Intermittent Preventive Treatment of malaria during pregnancy (IPTp). However, the prevalence of P. falciparum malaria and the status of malaria control vary markedly across the four sites with differences in the duration of the transmission season (from 4-5 to 10-11 months), the intensity of transmission (with EIRs from unmeasurably low to 4-5 per person per month), multiplicity of infection (from a mean of 1.0 to means of 2-5) and the status of malaria control (from areas which have virtually no control to areas that are at the threshold of malaria elimination). The most important priority is the need to obtain comparable data on the population-based prevalence, incidence and transmission of malaria before new candidate interventions or combinations of interventions are introduced for malaria control.


Acta Tropica | 1996

COMMUNITY PARTICIPATION IN THE CONTROL OF TROPICAL DISEASES

Donald J. Krogstad; Trenton K. Ruebush

The prevalence of tropical diseases depends on factors associated with poverty. These factors enhance the transmission of these diseases exacerbate associated conditions such as malnutrition and impair the host immune responses. In addition poverty limits the realistic options available for the long-term control of tropical diseases to those that are economical and sustainable by the developing countries where they are endemic. Because of the need for both economical and sustainable programs for the prevention and control of tropical diseases the participation of community residents in health interventions has always been viewed as an attractive approach. For many years community participation was rather loosely interpreted to include any involvement by community members in their own health care. Thus passive acceptance of health interventions imposed from outside the community such as vaccination campaigns or mass drug distribution for malaria were considered examples of community participation. More recently emphasis has been placed on the difference between passive acceptance and true community involvement in the choice design implementation and even the evaluation of disease control activities. The most obvious rationale for community involvement in disease prevention and control is a financial one. Community participation is essential to mobilize human resources and to draw upon the scarce material and financial resources available for disease control programs at the village level. At the same time it makes the limited resources available centrally go farther. For example the use of local materials for bed nets and the collective purchase of the synthetic pyrethroid insecticides to impregnate them can reduce their cost to a level that can be sustained by villagers in sub-Saharan Africa. (excerpt)

Collaboration


Dive into the Donald J. Krogstad's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daouda Ndiaye

Cheikh Anta Diop University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Davis Nwakanma

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge